A New Virus Vector for Safer Delivery of Gene Therapies in Ophthalmology

July 14, 2013

Researchers at UCal Berkeley have found a gene therapy vector that can deliver genes deep into the retina via intravitreous delivery, instead of using a needle to deliver the virus sub-retinally.

This eliminates the need for a vitrectomy, anesthesia and a hospital stay to treat patients, allowing for a simple short office visit and injection into the vitreous, similar to the way anti-VEGF drugs for age-related macular degeneration are currently delivered.

To read more, please follow this link.




Jump down to form below to submit your own comments

Comments are closed.